SCHEMBL26641295

SCHEMBL26641295

CC(C)(C)OC(=O)N1CC(F)(C#Cc2cccc(-c3ccc(OCc4ccccc4)nc3OCc3ccccc3)c2)C1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ YAP1 P46937 3/20 0.38
▸ CCNT1 O60563 1/20 0.36
▸ CCNA2 P20248 1/20 0.36
▸ CDK2 P24941 1/20 0.36
▸ CDK9 P50750 1/20 0.36
▸ CCNA1 P78396 1/20 0.36
▸ PRMT5 O14744 4/20 0.36
▸ TLR9 Q9NR96 3/20 0.36
▸ TLR7 Q9NYK1 2/20 0.36
▸ OPRD1 P41143 1/20 0.36
▸ OPRK1 P41145 1/20 0.36
▸ USP30 Q70CQ3 2/20 0.36
▸ ALOX5AP P20292 1/20 0.35
▸ FEN1 P39748 1/20 0.35
▸ SCD5 Q86SK9 1/20 0.35
▸ GPR119 Q8TDV5 1/20 0.35
▸ DGAT2 Q96PD7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30643651 1.00 YAP1 (0.38) YAP1CCNT1CCNA2CDK2CDK9
SCHEMBL26641237 0.91 PRMT5 (0.39) YAP1CCNT1CCNA2CDK2CDK9
SCHEMBL30643684 0.84 OPRD1 (0.42) YAP1CCNT1CCNA2CDK2CDK9
SCHEMBL30643626 0.84 TLR9 (0.36) YAP1CCNT1CCNA2CDK2CDK9
SCHEMBL26641508 0.82 OPRD1 (0.41) YAP1CCNT1CCNA2CDK2CDK9
SCHEMBL30830759 0.81 HSD17B10 (0.40) CCNT1CCNA2CDK2CDK9CCNA1
SCHEMBL26641379 0.81 PRMT5 (0.40) YAP1CCNT1CCNA2CDK2CDK9
SCHEMBL26641553 0.79 OPRD1 (0.42) YAP1CCNT1CCNA2CDK2CDK9
SCHEMBL30831067 0.79 HSD17B10 (0.51) USP30SCD5GPR119
SCHEMBL30965537 0.79 SCD5 (0.44) USP30SCD5GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023220640-A1 CDK PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2023-11-16 — — WO disclosed
Send feedback